Form 4 for BCDA BioCardia, Inc.
Accepted 2024-12-26 00:00:00 ET · period of report 2024-12-20 · accession 0001437749-24-038363 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-26 | 2024-12-20 | BCDA | GILLIS EDWARD M | SVP, Devices | S - Sale | $2.00 | -3,257 | 8,968 | -27% | -$6,514 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-20 | S | D | 3,257 | $2.00 | 8,968 | D | — | — | (F1) The reported sale transactions were effected for tax planning purposes. |